Vistagen Therapeutics, Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vistagen Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Vistagen Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2024 was -35.1 %, a 86.9% increase year-over-year.
  • Vistagen Therapeutics, Inc. annual Return On Equity for 2023 was -108 %, a 42.1% decline from 2022.
  • Vistagen Therapeutics, Inc. annual Return On Equity for 2022 was -76.2 %, a 26.4% increase from 2021.
  • Vistagen Therapeutics, Inc. annual Return On Equity for 2021 was -104 %, a 120% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -108 -32.1 -42.1% Apr 1, 2023 Mar 31, 2024
2022 -76.2 +27.4 +26.4% Apr 1, 2022 Mar 31, 2023
2021 -104 -622 -120% Apr 1, 2021 Mar 31, 2022
2020 519 +1.04K Apr 1, 2020 Mar 31, 2021
2019 -520 +140 +21.2% Apr 1, 2019 Mar 31, 2020
2018 -660 -234 -54.8% Apr 1, 2018 Mar 31, 2019
2017 -427 -894 -191% Apr 1, 2017 Mar 31, 2018
2016 468 +202 +76.1% Apr 1, 2016 Mar 31, 2017
2015 266 +153 +135% Apr 1, 2015 Mar 31, 2016
2014 113 +79.8 +241% Apr 1, 2014 Mar 31, 2015
2013 33.1 -163 -83.1% Apr 1, 2013 Mar 31, 2014
2012 196 Apr 1, 2012 Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.